Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT04303494
Eligibility Criteria:
Inclusion criteria for preterm infants:
* Gestational Age (GA) 22+0 to 31+6 weeks and/or birth weight 400 g to 1500 g
* Chronological age \> 7 days
* Written informed parental consent
Inclusion criteria for term healthy control infants:
* GA 37 to 42 weeks, chronological age 3 to 28 days (beyond initial transition after birth)
* Hospitalised in the neonatal rooming-in unit of the University Children's Hospital Basel as healthy co-twin or healthy sibling, or neonate ready to be discharged home after reconvalescence from minor illness such as hyperbilirubinaemia
* Written informed parental consent
Exclusion Criteria:
* Major congenital malformations including neuromuscular disorders, thoracic malformations, major cardiac malformation
* Lack of written informed parental consent
Sex:
ALL
Minimum Age:
3 Days
Maximum Age:
28 Days
Study:
NCT04303494
Study Brief:
Protocol Section:
NCT04303494